drugset / Trial / NCT00736229
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy of intravenous Exenatide therapy in hyperglycemic patients admitted to the coronary intensive care unit.
Timeline
- Start
- 2008-08
- Primary completion
- 2011-06
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 0.025 ug | Intravenous |